2
|
Ershadi R, Rafieian S, Salehi M, Kazemizadeh H, Amini H, Sohrabi M, Samimiat A, Sharafi Y, Dashtkoohi M, Vahedi M. COVID-19 and spontaneous pneumothorax: a survival analysis. J Cardiothorac Surg 2023; 18:211. [PMID: 37403072 DOI: 10.1186/s13019-023-02331-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Accepted: 06/29/2023] [Indexed: 07/06/2023] Open
Abstract
INTRODUCTION COVID-19 Patients may be at risk for involving with spontaneous pneumothorax. However, clinical data are lacking in this regard. In this study, we aimed to investigate the demographic, clinical, and radiological characteristics and survival predictors in COVID-19 patients with pneumothorax. METHODS This is a retrospectivestudy conducted on COVID-19 patients with pneumothorax that had been hospitalized at hospital. l from December 2021 to March 2022. The chest computed tomography (CT) scan of all patients was reviewed by an experienced pulmonologist in search of pulmonary pneumothorax. Survival analysis was conducted to identify the predictors of survival in patients with COVID-19 and pneumothorax. RESULTS A total of 67 patients with COVID-19 and pneumothorax were identified. Of these, 40.7% were located in the left lung, 40.7% were in the right lung, and 18.6% were found bilaterally. The most common symptoms in the patient with pneumothorax were dyspnea (65.7%), increased cough severity (53.7%), chest pain (25.4%), and hemoptysis (16.4%). The frequency of pulmonary left and right bullae, pleural effusion, andfungus ball were 22.4%, 22.4%, 22.4%, and 7.5%, respectively. Pneumothorax was managed with chest drain (80.6%), chest drain and surgery (6%), and conservatively (13.4%). The 50-day mortality rate was 52.2% (35 patients). The average survival time for deceased patients was 10.06 (2.17) days. CONCLUSIONS Our results demonstrated that those with pleural effusion or pulmonary bullae have a lower survival rate. Further studies are required to investigate the incidence and causality relation between COVID-19 and pneumothorax.
Collapse
Affiliation(s)
- Reza Ershadi
- Department of thoracic surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
| | - Shahab Rafieian
- Department of thoracic surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
| | - Mohammadreza Salehi
- Research center of Antibiotic stewardship & Anti-microbial resistance, Infectious diseases department, Imam Khomeini hospital complex, Tehran University of medical sciences, Tehran, Iran
| | - Hossein Kazemizadeh
- Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Hesam Amini
- Department of thoracic surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
| | - Marjan Sohrabi
- Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
| | - Alireza Samimiat
- Department of surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - Yaser Sharafi
- Department of surgery, Sina Hospital, Tehran University pf Medical Sciences, Tehran, Iran
| | | | - Matin Vahedi
- Department of surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
5
|
Wu X, Chen Q, Li J, Liu Z. Diagnostic techniques for COVID-19: A mini-review. J Virol Methods 2022; 301:114437. [PMID: 34933045 PMCID: PMC8684097 DOI: 10.1016/j.jviromet.2021.114437] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2020] [Revised: 12/14/2021] [Accepted: 12/17/2021] [Indexed: 02/07/2023]
Abstract
COVID-19, a new respiratory infectious disease, was first reported at the end of 2019, in Wuhan, China. Now, COVID-19 is still causing major loss of human life and economic productivity in almost all countries around the world. Early detection, early isolation, and early diagnosis of COVID-19 patients and asymptomatic carriers are essential to blocking the spread of the pandemic. This paper briefly reviewed COVID-19 diagnostic assays for clinical application, including nucleic acid tests, immunological methods, and Computed Tomography (CT) imaging. Nucleic acid tests (NAT) target the virus genome and indicates the existence of the SARS-CoV-2 virus. Currently, real-time quantitative PCR (qPCR) is the most widely used NAT and, basically, is the most used diagnostic assay for COVID-19. Besides qPCR, many novel rapid and sensitive NAT assays were also developed. Serological testing (detection of serum antibodies specific to SARS-CoV-2), which belongs to the immunological methods, is also used in the diagnosis of COVID-19. The positive results of serological testing indicate the presence of antibodies specific to SARS-CoV-2 resulting from being infected with the virus. Viral antigen detection assays are also important immunological methods used mainly for rapid virus detection. However, only a few of these assays had been reported. CT imaging is still an important auxiliary diagnosis tool for COVID-19 patients, especially for symptomatic patients in the early stage, whose viral load is low and different to be identified by NAT. These diagnostic techniques are all good in some way and applying a combination of them will greatly improve the accuracy of COVID-19 diagnostics.
Collapse
Affiliation(s)
- Xianyong Wu
- School of Life Sciences, Shanghai University, Shanghai, 200444, China
| | - Qiming Chen
- School of Life Sciences, Shanghai University, Shanghai, 200444, China
| | - Junhai Li
- Department of Oncology, No. 215 Hospital of Shaanxi Nuclear Industry, Xianyang City, Shaanxi Province, 712000, China.
| | - Zhanmin Liu
- School of Life Sciences, Shanghai University, Shanghai, 200444, China.
| |
Collapse
|
6
|
Komolafe TE, Cao Y, Nguchu BA, Monkam P, Olaniyi EO, Sun H, Zheng J, Yang X. Diagnostic Test Accuracy of Deep Learning Detection of COVID-19: A Systematic Review and Meta-Analysis. Acad Radiol 2021; 28:1507-1523. [PMID: 34649779 PMCID: PMC8445811 DOI: 10.1016/j.acra.2021.08.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Revised: 06/18/2021] [Accepted: 08/12/2021] [Indexed: 12/11/2022]
Abstract
RATIONALE AND OBJECTIVE To perform a meta-analysis to compare the diagnostic test accuracy (DTA) of deep learning (DL) in detecting coronavirus disease 2019 (COVID-19), and to investigate how network architecture and type of datasets affect DL performance. MATERIALS AND METHODS We searched PubMed, Web of Science and Inspec from January 1, 2020, to December 3, 2020, for retrospective and prospective studies on deep learning detection with at least reported sensitivity and specificity. Pooled DTA was obtained using random-effect models. Sub-group analysis between studies was also carried out for data source and network architectures. RESULTS The pooled sensitivity and specificity were 91% (95% confidence interval [CI]: 88%, 93%; I2 = 69%) and 92% (95% CI: 88%, 94%; I2 = 88%), respectively for 19 studies. The pooled AUC and diagnostic odds ratio (DOR) were 0.95 (95% CI: 0.88, 0.92) and 112.5 (95% CI: 57.7, 219.3; I2 = 90%) respectively. The overall accuracy, recall, F1-score, LR+ and LR- are 89.5%, 89.5%, 89.7%, 23.13 and 0.13. Sub-group analysis shows that the sensitivity and DOR significantly vary with the type of network architectures and sources of data with low heterogeneity are (I2 = 0%) and (I2 = 18%) for ResNet architecture and single-source datasets, respectively. CONCLUSION The diagnosis of COVID-19 via deep learning has achieved incredible performance, and the source of datasets, as well as network architectures, strongly affect DL performance.
Collapse
Affiliation(s)
- Temitope Emmanuel Komolafe
- School of Biomedical Engineering (Suzhou) (T.E.K.,Y.C., H.S.), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Department of Medical Imaging (T.E.K.,Y.C., H.S., J.Z., X.Y.), Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China; Hefei National Lab for Physical Sciences at the Microscale and Centres for Biomedical Engineering (B.A.N.), University of Science and Technology of China, Hefei, 230026, China; EasySignal Group, Department of Automation (P.M.), Tsinghua University, Beijing 100084, China; Department of Biomedical Engineering (E.O.O.), Shenzhen University, Shenzhen, 518060, China; Jinhua Laboratory (X.Y.), Foshan, 528000, China
| | - Yuzhu Cao
- School of Biomedical Engineering (Suzhou) (T.E.K.,Y.C., H.S.), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Department of Medical Imaging (T.E.K.,Y.C., H.S., J.Z., X.Y.), Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China; Hefei National Lab for Physical Sciences at the Microscale and Centres for Biomedical Engineering (B.A.N.), University of Science and Technology of China, Hefei, 230026, China; EasySignal Group, Department of Automation (P.M.), Tsinghua University, Beijing 100084, China; Department of Biomedical Engineering (E.O.O.), Shenzhen University, Shenzhen, 518060, China; Jinhua Laboratory (X.Y.), Foshan, 528000, China
| | - Benedictor Alexander Nguchu
- School of Biomedical Engineering (Suzhou) (T.E.K.,Y.C., H.S.), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Department of Medical Imaging (T.E.K.,Y.C., H.S., J.Z., X.Y.), Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China; Hefei National Lab for Physical Sciences at the Microscale and Centres for Biomedical Engineering (B.A.N.), University of Science and Technology of China, Hefei, 230026, China; EasySignal Group, Department of Automation (P.M.), Tsinghua University, Beijing 100084, China; Department of Biomedical Engineering (E.O.O.), Shenzhen University, Shenzhen, 518060, China; Jinhua Laboratory (X.Y.), Foshan, 528000, China
| | - Patrice Monkam
- School of Biomedical Engineering (Suzhou) (T.E.K.,Y.C., H.S.), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Department of Medical Imaging (T.E.K.,Y.C., H.S., J.Z., X.Y.), Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China; Hefei National Lab for Physical Sciences at the Microscale and Centres for Biomedical Engineering (B.A.N.), University of Science and Technology of China, Hefei, 230026, China; EasySignal Group, Department of Automation (P.M.), Tsinghua University, Beijing 100084, China; Department of Biomedical Engineering (E.O.O.), Shenzhen University, Shenzhen, 518060, China; Jinhua Laboratory (X.Y.), Foshan, 528000, China
| | - Ebenezer Obaloluwa Olaniyi
- School of Biomedical Engineering (Suzhou) (T.E.K.,Y.C., H.S.), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Department of Medical Imaging (T.E.K.,Y.C., H.S., J.Z., X.Y.), Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China; Hefei National Lab for Physical Sciences at the Microscale and Centres for Biomedical Engineering (B.A.N.), University of Science and Technology of China, Hefei, 230026, China; EasySignal Group, Department of Automation (P.M.), Tsinghua University, Beijing 100084, China; Department of Biomedical Engineering (E.O.O.), Shenzhen University, Shenzhen, 518060, China; Jinhua Laboratory (X.Y.), Foshan, 528000, China
| | - Haotian Sun
- School of Biomedical Engineering (Suzhou) (T.E.K.,Y.C., H.S.), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Department of Medical Imaging (T.E.K.,Y.C., H.S., J.Z., X.Y.), Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China; Hefei National Lab for Physical Sciences at the Microscale and Centres for Biomedical Engineering (B.A.N.), University of Science and Technology of China, Hefei, 230026, China; EasySignal Group, Department of Automation (P.M.), Tsinghua University, Beijing 100084, China; Department of Biomedical Engineering (E.O.O.), Shenzhen University, Shenzhen, 518060, China; Jinhua Laboratory (X.Y.), Foshan, 528000, China
| | - Jian Zheng
- School of Biomedical Engineering (Suzhou) (T.E.K.,Y.C., H.S.), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Department of Medical Imaging (T.E.K.,Y.C., H.S., J.Z., X.Y.), Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China; Hefei National Lab for Physical Sciences at the Microscale and Centres for Biomedical Engineering (B.A.N.), University of Science and Technology of China, Hefei, 230026, China; EasySignal Group, Department of Automation (P.M.), Tsinghua University, Beijing 100084, China; Department of Biomedical Engineering (E.O.O.), Shenzhen University, Shenzhen, 518060, China; Jinhua Laboratory (X.Y.), Foshan, 528000, China
| | - Xiaodong Yang
- School of Biomedical Engineering (Suzhou) (T.E.K.,Y.C., H.S.), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Department of Medical Imaging (T.E.K.,Y.C., H.S., J.Z., X.Y.), Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China; Hefei National Lab for Physical Sciences at the Microscale and Centres for Biomedical Engineering (B.A.N.), University of Science and Technology of China, Hefei, 230026, China; EasySignal Group, Department of Automation (P.M.), Tsinghua University, Beijing 100084, China; Department of Biomedical Engineering (E.O.O.), Shenzhen University, Shenzhen, 518060, China; Jinhua Laboratory (X.Y.), Foshan, 528000, China.
| |
Collapse
|
7
|
Pattanashetti L, Patil S, Nyamgouda S, Bhagiratha M, Gadad P. COVID-19 and pregnant women - An overview on diagnosis, treatment approach with limitation, and clinical management. Monaldi Arch Chest Dis 2021; 91. [PMID: 34121377 DOI: 10.4081/monaldi.2021.1785] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2021] [Accepted: 04/15/2021] [Indexed: 01/08/2023] Open
Abstract
Coronavirus disease or more popularly called COVID-19 is known to be caused by a novel coronavirus 2. The COVID-19 has been identified to be originated from Wuhan, Hubei, China. This pandemic started in December 2019, and since then it has spread across the world within a short period. The health and family welfare ministry of the Government of India reported 227,546 active, 9,997,272 discharged cases, and 150,114 deaths due to COVID-19 as of 06 January 2021. Indian Council of Medical Research (ICMR) reports that the cumulative testing status of SARS-CoV-2 (COVID-19) was 931,408 up to November 03, 2020. Currently, no specific anti-viral drug for COVID-19 management is recommended in the current scenario. Vulnerable populations such as pregnant women affected by COVID-19 infection need to be recognized and followed up for effective handling concerning morbidity and mortality. At present, very few case reports on COVID-19 infected pregnant women have been published in India and there is no proven exclusive treatment protocol. This article summarizes a review of signs and symptoms, etiopathogenesis, risk factors, diagnosis, and possible management of COVID-19 infection in pregnant women. This overview may be useful for health care providers for practical approach and limitation of drugs used in the current management and considers the choice of drugs with their special attention given to adverse effects to improvise maternal health, pregnancy, and birth outcomes.
Collapse
Affiliation(s)
- Laxmi Pattanashetti
- Department of Pharmacology, KLE College of Pharmacy, Hubli (A constituent unit of KLE Academy of Higher Education and Research, Belagavi), Karnataka.
| | - Santosh Patil
- Department of Pharmacology, KLE College of Pharmacy, Hubli (A constituent unit of KLE Academy of Higher Education and Research, Belagavi), Karnataka.
| | - Sanath Nyamgouda
- Department of Pharmacy Practice, KLE College of Pharmacy, Hubli (A constituent unit of KLE Academy of Higher Education and Research, Belagavi, Karnataka.
| | - Mahendrakumar Bhagiratha
- Department of Pharmacy Practice, KLE College of Pharmacy, Hubli (A constituent unit of KLE Academy of Higher Education and Research, Belagavi, Karnataka.
| | - Pramod Gadad
- Department of Pharmacology, KLE College of Pharmacy, Hubli (A constituent unit of KLE Academy of Higher Education and Research, Belagavi), Karnataka.
| |
Collapse
|
9
|
Reginelli A, Grassi R, Feragalli B, Belfiore MP, Montanelli A, Patelli G, La Porta M, Urraro F, Fusco R, Granata V, Petrillo A, Giacobbe G, Russo GM, Sacco P, Grassi R, Cappabianca S. Coronavirus Disease 2019 (COVID-19) in Italy: Double Reading of Chest CT Examination. BIOLOGY 2021; 10:biology10020089. [PMID: 33504028 PMCID: PMC7911408 DOI: 10.3390/biology10020089] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Accepted: 01/22/2021] [Indexed: 12/28/2022]
Abstract
To assess the performance of the second reading of chest compute tomography (CT) examinations by expert radiologists in patients with discordance between the reverse transcription real-time fluorescence polymerase chain reaction (RT-PCR) test for COVID-19 viral pneumonia and the CT report. Three hundred and seventy-eight patients were included in this retrospective study (121 women and 257 men; 71 years median age, with a range of 29-93 years) and subjected to RT-PCR tests for suspicious COVID-19 infection. All patients were subjected to CT examination in order to evaluate the pulmonary disease involvement by COVID-19. CT images were reviewed first by two radiologists who identified COVID-19 typical CT patterns and then reanalyzed by another two radiologists using a CT structured report for COVID-19 diagnosis. Weighted к values were used to evaluate the inter-reader agreement. The median temporal window between RT-PCRs execution and CT scan was zero days with a range of (-9,11) days. The RT-PCR test was positive in 328/378 (86.8%). Discordance between RT-PCR and CT findings for viral pneumonia was revealed in 60 cases. The second reading changed the CT diagnosis in 16/60 (26.7%) cases contributing to an increase the concordance with the RT-PCR. Among these 60 cases, eight were false negative with positive RT-PCR, and 36 were false positive with negative RT-PCR. Sensitivity, specificity, positive predictive value and negative predictive value of CT were respectively of 97.3%, 53.8%, 89.0%, and 88.4%. Double reading of CT scans and expert second readers could increase the diagnostic confidence of radiological interpretation in COVID-19 patients.
Collapse
Affiliation(s)
- Alfonso Reginelli
- Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80121 Naples, Italy; (A.R.); (R.G.); (M.P.B.); (F.U.); (G.G.); (G.M.R.); (R.G.); (S.C.)
| | - Roberta Grassi
- Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80121 Naples, Italy; (A.R.); (R.G.); (M.P.B.); (F.U.); (G.G.); (G.M.R.); (R.G.); (S.C.)
| | - Beatrice Feragalli
- Oral and Biotechnological Sciences—Radiology Unit “G. D’Annunzio”, Department of Medical, University of Chieti-Pescara, 66100 Chieti, Italy;
| | - Maria Paola Belfiore
- Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80121 Naples, Italy; (A.R.); (R.G.); (M.P.B.); (F.U.); (G.G.); (G.M.R.); (R.G.); (S.C.)
| | | | | | | | - Fabrizio Urraro
- Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80121 Naples, Italy; (A.R.); (R.G.); (M.P.B.); (F.U.); (G.G.); (G.M.R.); (R.G.); (S.C.)
| | - Roberta Fusco
- Radiology Division, Istituto Nazionale Tumori IRCCS Fondazione Pascale—IRCCS di Napoli, 80131 Naples, Italy; (V.G.); (A.P.)
- Correspondence: ; Tel.: +39-081-590-3714
| | - Vincenza Granata
- Radiology Division, Istituto Nazionale Tumori IRCCS Fondazione Pascale—IRCCS di Napoli, 80131 Naples, Italy; (V.G.); (A.P.)
| | - Antonella Petrillo
- Radiology Division, Istituto Nazionale Tumori IRCCS Fondazione Pascale—IRCCS di Napoli, 80131 Naples, Italy; (V.G.); (A.P.)
| | - Giuliana Giacobbe
- Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80121 Naples, Italy; (A.R.); (R.G.); (M.P.B.); (F.U.); (G.G.); (G.M.R.); (R.G.); (S.C.)
| | - Gaetano Maria Russo
- Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80121 Naples, Italy; (A.R.); (R.G.); (M.P.B.); (F.U.); (G.G.); (G.M.R.); (R.G.); (S.C.)
| | - Palmino Sacco
- Diagnostic Imaging Unit, Department of Radiological Sciences, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy;
| | - Roberto Grassi
- Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80121 Naples, Italy; (A.R.); (R.G.); (M.P.B.); (F.U.); (G.G.); (G.M.R.); (R.G.); (S.C.)
- Foundation SIRM, 20122 Milan, Italy
| | - Salvatore Cappabianca
- Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80121 Naples, Italy; (A.R.); (R.G.); (M.P.B.); (F.U.); (G.G.); (G.M.R.); (R.G.); (S.C.)
| |
Collapse
|